Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
about
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisBlood pressure targets for hypertension in older adultsAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisImproving the reporting of pragmatic trials: an extension of the CONSORT statementPrevalence of comorbidity of chronic diseases in AustraliaRandomized controlled trials - a matter of designPharmacotherapy in the management of asthma in the elderly: a review of clinical studiesOpioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaMultimorbidity and evidence generationInforming evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseasesIdentifying the appropriate comparison group for HIV-infected individualsThe research-treatment distinction: a problematic approach for determining which activities should have ethical oversightComparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological studyCardiovascular toxicity of multi-tyrosine kinase inhibitors in advanced solid tumors: a population-based observational studyRisk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias ToolThe promotion of data sharing in pharmacoepidemiologySPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsCellulite and extracorporeal Shockwave therapy (CelluShock-2009)--a randomized trialInterpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults.Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry.A Practical, Global Perspective on Using Administrative Data to Conduct Intensive Care Unit Research.The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.Routinely collected data and comparative effectiveness evidence: promises and limitations.How Well Do Randomized Controlled Trials Reflect Standard Care: A Comparison between Scientific Research Data and Standard Care Data in Patients with Intermittent Claudication undergoing Supervised Exercise Therapy.Improving precision medicine using individual patient data from trials.Automatic data source identification for clinical trial eligibility criteria resolution.Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.Frailty Intervention Trial (FIT)The external validity of published randomized controlled trials in primary care.A practical approach to the pharmacological management of hypertension in older people.IOM and DHHS meeting on making clinical practice guidelines appropriate for patients with multiple chronic conditions.Differences in clinical trial patient attributes and outcomes according to enrollment setting.Making general internal medicine research relevant to the older patient with multiple chronic comorbidities.Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient groupCo-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences.Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritisAre statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in FinlandA distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.Formal representation of eligibility criteria: a literature review
P2860
Q24186663-F321BDF1-7981-4597-9747-458F4C0EC592Q24187725-A3AD4EE5-D452-4C8A-9D73-0FAF26A4FDE8Q24235637-6E0109AE-620F-4351-A5E1-448094D99B32Q24602353-60F98A83-0CDF-4080-ABBC-03DF7F28E6D9Q24657304-4CC97F17-7C5E-466F-B272-52B902C41727Q26746217-7BD9D978-1FED-44FB-A212-23881B261BAFQ26769046-2736E479-8BDD-4EDC-AE3D-B33ECF19F027Q26778626-6D508DB5-8C66-40F9-846B-7D6579CB3B89Q27014802-A3800EC2-285E-4E3D-9F8E-077359169AFEQ27023214-E744C64A-8D3C-419F-B98D-CAB330A47918Q27028033-5A910C34-18A4-4A06-89CC-0BD803AEC514Q28283204-143CAA16-4636-46D6-A2E2-1A4BA1119E0AQ28533341-9C865383-B9D0-45D7-9322-C22A53D2280DQ28545130-10639C2C-20D8-48E3-8017-8DC2FFA1B5A8Q28551188-6C69CED2-DA0E-4F03-A4AD-291956ED231AQ28651499-A61B289F-DF34-4784-9DCC-638C2C3167B8Q28710019-C5CFF5BC-2244-4764-AFF8-E913799C94A7Q30478620-4DCD67FB-78C8-4D97-8A81-B2D4114A3354Q30585651-4ABD2B6F-36A4-4C09-BD5B-CA61842A74C0Q30964995-2A2497AB-06CC-4AF8-B98E-D6118FD3201CQ30978879-DC331FEF-E496-48F6-AC44-0104047ADF59Q31036332-BABCE825-1E98-48AC-B848-56A3A23328FCQ31046490-0F4317AB-D4E7-466C-A3F5-4AAEB17FFE81Q31110231-35BEC754-5A7D-4459-B11D-2BD8E0853659Q31125430-1041A0B6-C979-4530-9E90-BF98492079F2Q31172251-B28140E6-555B-459D-B3ED-74A8D1B30CF9Q33164540-6DDFC8B5-CE53-440E-93E1-0A8A093B7DBEQ33375524-09375E0B-3F59-47DE-ADC9-001BCE910B9DQ33400855-1762B11F-C915-4745-8DC8-F5757BBB1303Q33572617-AEC30A85-462E-4E1E-BC90-E100FCF5112CQ33599695-BA72DD21-6D28-40BB-B139-704BC6837FC9Q33627769-CDA0807C-1604-4AB7-812D-AF82A7F9F1A3Q33633120-8C25D358-D32F-4CFD-9754-8239EFBAA850Q33642179-ADB25887-3496-4921-A020-C3185C0D8158Q33712975-24FA1756-120A-4600-8BE7-283AAF0E211AQ33750206-3E8A9D05-BCEA-4762-80B3-AD363E80770EQ33780502-30EB374B-C823-4A5B-9040-9AE0A77587FCQ33795544-4F453BBC-D845-4C3C-A771-598BB6264753Q33845832-637575A8-6027-458C-87D7-184BB76678EDQ33886631-97DCCCA0-B6AA-478B-B723-3F01AF842E73
P2860
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Eligibility criteria of random ...... a systematic sampling review.
@ast
Eligibility criteria of random ...... a systematic sampling review.
@en
Eligibility criteria of random ...... a systematic sampling review.
@nl
type
label
Eligibility criteria of random ...... a systematic sampling review.
@ast
Eligibility criteria of random ...... a systematic sampling review.
@en
Eligibility criteria of random ...... a systematic sampling review.
@nl
prefLabel
Eligibility criteria of random ...... a systematic sampling review.
@ast
Eligibility criteria of random ...... a systematic sampling review.
@en
Eligibility criteria of random ...... a systematic sampling review.
@nl
P2093
P356
P1476
Eligibility criteria of random ...... a systematic sampling review.
@en
P2093
Andrew Toren
Harriette G C Van Spall
Robert A Fowler
P304
P356
10.1001/JAMA.297.11.1233
P407
P577
2007-03-01T00:00:00Z